18 results with keyword: 'phase i study of granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium'
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60 micrograms/kg of body weight to 22 patients with transitional cell carcinoma
N/A
Phase I/Il study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Gabrilove JL, Jakubowski A, Fain
N/A
Duration of prophylactic granulocyte-colony stimulating factor Education for patients receiving granulocyte-colony stimulating factors Recommendations for the use of
N/A
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell
N/A
APC: Antigen-presenting cell; CI: Confidence interval; G-CSF: Granulocyte-colony stimulating factor; GM-CSF: Granulocyte-macrophage colony stimulating factor; ICU: Intensive care
N/A
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III
N/A
The myeloid growth factors, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating
N/A
The HGFs including erythropoietin (EPO), granulocyte macrophage colony-stimulating factor (GMCSF), granulocyte colony-stimulating factor (GCSF),
N/A
RCC, renal cell carcinoma; ccRCC, clear cell renal cell carcinoma; UISS, University of California Integrated Staging System; SSIGN, Mayo Clinic stage, size, grade, and necrosis;
N/A
EnhanceMent After Stroke (STEMS) Pilot Randomized, Controlled Trial Patients With Subacute Ischemic Stroke: The Stem Cell Trial of Recovery Granulocyte-Colony-Stimulating
N/A
The well-documented effect of the growth factors (granulocyte colony-stimulating factor [G-CSF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) in acute
N/A
Rowe JM, Andersen JW, Mazza JJ et al (1995) A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55
N/A
5-HMT: 5-Hydroxymethyl tolterodine; BP: Basal pressure; BOO: Bladder outlet obstruction; BDNF: Brain derived-neurotrophic factor; UCs: Cultured urothelial cells;
N/A
EGF, epidermal growth factor; FGF, fibroblast growth factor; G-CSF, granulocyte colony stimulating factor; GM-CSF, granulocyte- macrophage colony stimulating factor; IL,
N/A
Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/ granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors
N/A
G-CSF: Granulocyte-colony stimulating factor; GM-CSF: Granulocyte-macrophage- colony stimulating factor; HGF: Hepatocyte growth factor; ICAM: Intercellular adhesion molecule;
N/A
CRP: C-reactive protein; FGF: Fibroblast growth factor; G-CSF: Granulocyte colony-stimulating factor; GM-CSF: Granulocyte macrophage colony- stimulating factor; Ig: Immunoglobulin;
N/A
Incorporation of the intratumoral GM-CSF expression into a prognostic model including TNM stage, Fuhrman grade, tumor necrosis and lymphovascular invasion generated a nomogram,
N/A